Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and ...
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback